Biohit Oyj B Total Assets

Latest as of December 2025: €19.80 Million EUR ≈ $23.15 Million USD

Biohit Oyj B total assets. Based on the latest financial reports, Biohit Oyj B (BIOBV) holds total assets worth €19.80 Million EUR (≈ $23.15 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Biohit Oyj B (BIOBV) cash conversion ratio for how efficiently the company converts equity into cash flow.

Total Assets of Biohit Oyj B (2000–2025)

Total assets of Biohit Oyj B from 2000 to 2025. This chart illustrates how Biohit Oyj B's total assets have evolved over time, based on quarterly financial data. See BIOBV stock price for real-time trading data and today's change.

Biohit Oyj B - Asset Composition Analysis

Biohit Oyj B Total Assets Breakdown (December 2025)

Biohit Oyj B total assets breakdown as of December 2025. Biohit Oyj B's total assets of €19.80 Million consist of 46.0% current assets and 54.0% non-current assets. Explore Biohit Oyj B (BIOBV) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€3.50 Million	17.7%
Accounts Receivable	€3.60 Million	18.2%
Inventory	€800.00K	4.0%
Property, Plant & Equipment	€1.90 Million	9.6%
Intangible Assets	€700.00K	3.5%
Goodwill	€0.00	0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how Biohit Oyj B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Biohit Oyj B's current assets represent 46.0% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 17.7% of total assets in 2025, up from 12.3% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 38.0% in 2000.
Asset Diversification: The largest asset category is accounts receivable at 18.2% of total assets.

Biohit Oyj B Competitors by Total Assets

Key competitors of Biohit Oyj B based on total assets are shown below.

Company	Country	Total Assets
Medtronic plc SA:MDTC34	Brazil	R$93.03 Billion
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Sequana Medical NV BR:SEQUA	Belgium	€14.57 Million
Cleo Diagnostics Ltd AU:COV	Australia	AU$9.96 Million
Epitomee Medical Ltd TA:EPIT	Israel	ILA37.04 Million
Aroa Biosurgery Ltd AU:ARX	Australia	AU$95.27 Million
ViroGates A/S CO:VIRO	Denmark	Dkr26.77 Million
Spineguard PA:ALSGD	France	€8.35 Million

Biohit Oyj B - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.53	3.67	4.28
Quick Ratio	2.31	3.33	3.81
Cash Ratio	0.97	1.25	0.00
Working Capital	€5.50 Million	€8.00 Million	€6.36 Million

Biohit Oyj B - Advanced Valuation Insights

This section examines the relationship between Biohit Oyj B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.89
Latest Market Cap to Assets Ratio	1.50
Asset Growth Rate (YoY)	27.7%
Total Assets	€19.80 Million
Market Capitalization	$29.72 Million USD

Valuation Analysis

Above Book Valuation: The market values Biohit Oyj B's assets above their book value (1.50x), reflecting positive investor sentiment about the company's future prospects.

Rapid Asset Growth: Biohit Oyj B's assets grew by 27.7% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Biohit Oyj B (2000–2025)

The table below shows the annual total assets of Biohit Oyj B from 2000 to 2025.

Year	Total Assets	Change
2025-12-31	€19.80 Million ≈ $23.15 Million	+27.74%
2024-12-31	€15.50 Million ≈ $18.12 Million	+19.97%
2023-12-31	€12.92 Million ≈ $15.10 Million	+17.29%
2022-12-31	€11.02 Million ≈ $12.88 Million	+14.58%
2021-12-31	€9.61 Million ≈ $11.24 Million	-10.80%
2020-12-31	€10.78 Million ≈ $12.60 Million	-37.96%
2019-12-31	€17.37 Million ≈ $20.31 Million	-2.88%
2018-12-31	€17.89 Million ≈ $20.91 Million	-5.33%
2017-12-31	€18.89 Million ≈ $22.09 Million	+45.47%
2016-12-31	€12.99 Million ≈ $15.19 Million	+10.75%
2015-12-31	€11.73 Million ≈ $13.71 Million	-19.16%
2014-12-31	€14.51 Million ≈ $16.96 Million	-48.74%
2013-12-31	€28.30 Million ≈ $33.09 Million	-29.26%
2012-12-31	€40.01 Million ≈ $46.77 Million	-44.02%
2011-12-31	€71.47 Million ≈ $83.56 Million	+143.24%
2010-12-31	€29.38 Million ≈ $34.35 Million	+7.24%
2009-12-31	€27.40 Million ≈ $32.03 Million	+1.08%
2008-12-31	€27.11 Million ≈ $31.69 Million	-0.84%
2007-12-31	€27.34 Million ≈ $31.96 Million	+0.07%
2006-12-31	€27.32 Million ≈ $31.94 Million	-1.91%
2005-12-31	€27.85 Million ≈ $32.56 Million	+22.37%
2004-12-31	€22.76 Million ≈ $26.61 Million	+4.04%
2003-12-31	€21.88 Million ≈ $25.57 Million	-2.40%
2002-12-31	€22.41 Million ≈ $26.20 Million	-10.33%
2001-12-31	€25.00 Million ≈ $29.22 Million	-82.93%
2000-12-31	€146.42 Million ≈ $171.18 Million	--

About Biohit Oyj B

HE:BIOBV Finland Medical Devices

Market Cap

$29.72 Million

€25.42 Million EUR

Market Cap Rank

#23677 Global

#123 in Finland

Share Price

€2.08

Change (1 day)

-1.89%

52-Week Range

€2.08 - €3.70

All Time High

€6.47